Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion — Stella

Home/Hepatitis B, Chronic/Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

View on ClinicalTrials.gov

Recruiting

Back to Hepatitis B, Chronic trials

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

Trial locations(1 site)

China

Fahong Li, Shanghai, Shanghai Municipality

Key details

Sponsor

Huashan Hospital

Enrollment target

~300 participants

Started

August 2024

Primary completion

August 2027

Age range

18 Years – 65 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.